Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Acelrx Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Acelrx Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
StockNews.com Downgrades Marinus Pharmaceuticals (NASDAQ:MRNS) to Sell via ETF Daily News
Adamis Pharmaceuticals (NASDAQ:ADMP) Stock Price Crosses Below Two Hundred Day Moving Average of $0.54 via ETF Daily News
Concert Pharmaceuticals (NASDAQ:CNCE) Share Price Crosses Above 50 Day Moving Average of $4.15 via ETF Daily News
Reviewing Kodiak Sciences (NASDAQ:KOD) & X4 Pharmaceuticals (NASDAQ:XFOR) via ETF Daily News
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Sees Significant Increase in Short Interest via ETF Daily News
Short Interest in Nuvo Pharmaceuticals Inc. (OTCMKTS:MRVFF) Expands By 337.5% via ETF Daily News
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Down 0.6% via ETF Daily News
CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews.com via ETF Daily News
Adamis Pharmaceuticals (NASDAQ:ADMP) Receives New Coverage from Analysts at StockNews.com via ETF Daily News
Corvus Pharmaceuticals (NASDAQ:CRVS) Earns Sell Rating from Analysts at StockNews.com via ETF Daily News
Acelrx Pharmaceuticals Inc Performance
Active Alerts for IEX:ACRX
You don't have any alerts set for IEX:ACRX.
About Acelrx Pharmaceuticals Inc
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
Real-time ACRX to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.